Insulin-dependent diabetes mellitus is an autoimmune disease characterized by specific destruction of the insulin-producing beta cells of the islets of Langerhans of the pancreas. It is thought to be a regulated disease because the initiation of insulitis and the transition form insulitis to diabetes are neither automatic nor immediate in susceptible individuals. The overall goal of the proposed project is to define the roles of co- stimulatory molecules are important regulators of diabetes progression, different receptor: ligand pairs exerting their influences on discrete events through pathogenesis. Consequently, the major strategy is to exploit three simple, highly manipulable derivatives of the BDC2.5 TCR tg model of diabetes that permit one to specifically focus on particular events: the initiation of insulitis, the transition from insulitis to diabetes or regulatory T cell control of the insulitis to diabetes conversion. Subsequent studies begin by building on existing information on the role of the DCD28/152:CD80/86 quarter of co-stimulatory molecules in diabetes progression and move on to the exciting new challenge of elucidating the role of the recently identified co-stimulatory receptor, ICOS.
The specific aims are to: i) elucidate the roles of CD152 and CD28 at disease initiation; ii) establish the function of CD80 and CD86 in the unfolding of diabetes; iii) determine the role of ICOS during diabetes development. These studies should generate novel information on the role of co- stimulatory molecules in controlling immune responses, in particular autoimmune disease; this information may suggest novel strategies for therapeutic intervention importantly, even when disease is ongoing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI039671-07
Application #
6654528
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-09-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Ponath, Gerald; Lincoln, Matthew R; Levine-Ritterman, Maya et al. (2018) Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat Commun 9:5337
Sumida, Tomokazu; Lincoln, Matthew R; Ukeje, Chinonso M et al. (2018) Activated ?-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity. Nat Immunol 19:1391-1402
Meyer Zu Horste, Gerd; Przybylski, Dariusz; Schramm, Markus A et al. (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48:556-569.e7
Chihara, Norio; Madi, Asaf; Kondo, Takaaki et al. (2018) Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558:454-459
Ordovas-Montanes, Jose; Dwyer, Daniel F; Nyquist, Sarah K et al. (2018) Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560:649-654
Mead, Benjamin E; Ordovas-Montanes, Jose; Braun, Alexandra P et al. (2018) Harnessing single-cell genomics to improve the physiological fidelity of organoid-derived cell types. BMC Biol 16:62
Wu, Chuan; Chen, Zuojia; Xiao, Sheng et al. (2018) SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells. Cell Rep 22:653-665
Lucca, Liliana E; Hafler, David A (2017) Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment. J Clin Invest 127:1218-1220
Joller, Nicole; Kuchroo, Vijay K (2017) Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol 410:127-156
Nylander, Alyssa N; Ponath, Gerald D; Axisa, Pierre-Paul et al. (2017) Podoplanin is a negative regulator of Th17 inflammation. JCI Insight 2:

Showing the most recent 10 out of 205 publications